Impact of UGT1A1 genetic polymorphism on toxicity in unresectable pancreatic cancer patients undergoing FOLFIRINOX.
- DOI
- 10.1111/cas.13883
- Published
- 2019 Feb
- Container
- Cancer science
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/cas.13883,
title = {Impact of UGT1A1 genetic polymorphism on toxicity in unresectable pancreatic cancer patients undergoing FOLFIRINOX.},
author = {Shirasu H and Todaka A and Omae K and Fujii H and Mizuno N and Ozaka M and Ueno H and Kobayashi S and Uesugi K and Kobayashi N and Hayashi H and Sudo K and Okano N and Horita Y and Kamei K and Yukisawa S and Kobayashi M and Fukutomi A},
year = {2019},
journal = {Cancer science},
doi = {10.1111/cas.13883},
url = {https://doi.org/10.1111/cas.13883}
}RIS
TY - JOUR TI - Impact of UGT1A1 genetic polymorphism on toxicity in unresectable pancreatic cancer patients undergoing FOLFIRINOX. AU - Shirasu H AU - Todaka A AU - Omae K AU - Fujii H AU - Mizuno N AU - Ozaka M AU - Ueno H AU - Kobayashi S AU - Uesugi K AU - Kobayashi N AU - Hayashi H AU - Sudo K AU - Okano N AU - Horita Y AU - Kamei K AU - Yukisawa S AU - Kobayashi M AU - Fukutomi A PY - 2019 JO - Cancer science DO - 10.1111/cas.13883 UR - https://doi.org/10.1111/cas.13883 ER -
APA
H, S., A, T., K, O., H, F., N, M., M, O., H, U., S, K., K, U., N, K., H, H., K, S., N, O., Y, H., K, K., S, Y., M, K., & A, F. (2019). Impact of UGT1A1 genetic polymorphism on toxicity in unresectable pancreatic cancer patients undergoing FOLFIRINOX.. Cancer science. https://doi.org/10.1111/cas.13883
Source records
- pubmed · retrieved 2026-09-26T16:04:29.419Z
- europe-pmc · retrieved 2026-09-26T16:04:29.420Z